PH10639A - Method of treatment and composition containing silver sulfadiazine - Google Patents

Method of treatment and composition containing silver sulfadiazine

Info

Publication number
PH10639A
PH10639A PH9358A PH9358A PH10639A PH 10639 A PH10639 A PH 10639A PH 9358 A PH9358 A PH 9358A PH 9358 A PH9358 A PH 9358A PH 10639 A PH10639 A PH 10639A
Authority
PH
Philippines
Prior art keywords
silver
heavy metal
treatment
july
compositions
Prior art date
Application number
PH9358A
Inventor
C Fox
Original Assignee
Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Corp filed Critical Research Corp
Publication of PH10639A publication Critical patent/PH10639A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

1,240,546. Medicines containing antibiotics and sulphonamides. RESEARCH CORP. 16 July, 1968 [17 July, 1967], No. 49459/70. Divided out of 1,240,545. Heading A5B. A pharmaceutical composition comprises a heavy metal salt of an antibiotic in admixture with a heavy metal salt of a sulphonamide and/or silver salicylate. The heavy metal salts may be those of gold, nickel, tin, zinc, mercury, platinum, osmium, molybdenum, titanium, copper or silver (preferred). Specified are silver salts of penicillin, cephalothin, colistimethate, and tetracycline; and silver salts of sulphamerazine, sulphonanilide, sulphathiazole, sulphapyridine, sulphamylon, sulphoxazole, sulphapyrimidine, sulphaquinoxaline, substituted benzene sulphonamide and sulphamyl benzothiadiazine dioxide. The compositions may be in the form of a powder, an aqueous suspension, ointment, aerosol or may be incorporated in a film-forming material. Aqueous solutions containing chloride ions e.g. NaCl may be used as carriers for the active ingredients. Specification 1,240,545 is referred to. The compositions are useful in the treatment of burns.
PH9358A 1967-07-17 1968-07-05 Method of treatment and composition containing silver sulfadiazine PH10639A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65383067A 1967-07-17 1967-07-17

Publications (1)

Publication Number Publication Date
PH10639A true PH10639A (en) 1977-07-22

Family

ID=24622450

Family Applications (1)

Application Number Title Priority Date Filing Date
PH9358A PH10639A (en) 1967-07-17 1968-07-05 Method of treatment and composition containing silver sulfadiazine

Country Status (8)

Country Link
BE (1) BE718183A (en)
DE (1) DE1792053B1 (en)
ES (1) ES356142A1 (en)
FR (2) FR1586125A (en)
GB (2) GB1240545A (en)
IE (1) IE32197B1 (en)
NL (1) NL6809794A (en)
PH (1) PH10639A (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4049802A (en) 1975-03-19 1977-09-20 Research Corporation Zinc sulfadiazine and its use in the treatment of burns
DE2804931A1 (en) * 1978-02-06 1979-08-16 Fresenius Chem Pharm Ind METAL SULFADIAZINE IN FINE PARTICULAR FORM
US4384117A (en) * 1980-03-18 1983-05-17 The United States Of America As Represented By The Secretary Of The Army Silver metachloridine
US4933330A (en) * 1987-04-01 1990-06-12 Dak-Laboratoriet Benzoic acid derivatives and use thereof
CA2024220A1 (en) * 1990-08-29 1992-03-01 Don Simmons Composition containing silver sulfadiazine and benzocaine for use in the treatment of wounds following laser surgery
IT1243435B (en) * 1990-10-05 1994-06-10 Altergon Sa PHARMACEUTICAL COMPOSITIONS FOR TOPICAL USE INCLUDING HYALURONIC ACID SODIUM SALT AND DISINFECTANT SUBSTANCES
RS44204A (en) 2001-11-22 2007-06-04 Biovitrum Ab., Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
US7173030B2 (en) 2003-05-21 2007-02-06 Biovitrum Ab Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
WO2004103980A1 (en) * 2003-05-21 2004-12-02 Biovitrum Ab Inhibitors of 11-beta-hydroxy steroid dehydrogenase type i
SE0301885D0 (en) * 2003-06-25 2003-06-25 Biovitrum Ab New use IV
SE0301888D0 (en) * 2003-06-25 2003-06-25 Biovitrum Ab New use VII
SE0301884D0 (en) * 2003-06-25 2003-06-25 Biovitrum Ab New use III
SE0301882D0 (en) * 2003-06-25 2003-06-25 Biovitrum Ab New use I
SE0301886D0 (en) * 2003-06-25 2003-06-25 Biovitrum Ab New use V
WO2004113310A1 (en) * 2003-06-25 2004-12-29 Biovitrum Ab Use of an inhibitor of 11-b-hydroxysteroid dehydrogenase type 1 compounds for promoting wound healing
BRPI1104620B1 (en) * 2011-09-09 2020-04-07 Lucia Teixeira De Carvalho pharmaceutical composition for the treatment of burns and skin lesions and their preparation process

Also Published As

Publication number Publication date
NL6809794A (en) 1969-01-21
GB1240546A (en) 1971-07-28
FR1586125A (en) 1970-02-13
ES356142A1 (en) 1970-02-16
IE32197B1 (en) 1973-05-16
GB1240545A (en) 1971-07-28
FR8146M (en) 1970-08-17
IE32197L (en) 1969-01-17
BE718183A (en) 1969-01-17
DE1792053B1 (en) 1971-07-29

Similar Documents

Publication Publication Date Title
FR8146M (en)
ES475035A1 (en) Amino or acylamino-substituted pyrimidinyl cephalosporanic acid derivatives and pharmaceutical compositions thereof
GB1397073A (en) 1,2,4-oxadizoles
GB1295489A (en)
GB1419121A (en) Heterocyclic-fused triazole derivatives and their use in controlling plant pathogenic organisms
GB1292410A (en) Thienobenzothiazepine derivatives
GB1361198A (en) Disulphide compounds and process for their manufa'ture
ES8402315A1 (en) Aminoglycoside derivatives, processes for their production, pharmaceutical compositions containing them and such derivatives for use as pharmaceuticals.
GB1252286A (en)
GB1350878A (en) Coumarin derivatives and production thereof
GB1276061A (en) Tetronic acid derivatives, process for the manufacture thereof, and compositions containing such compounds
GB1314899A (en) Thiosemicarbazones processes for their preparations and compositions incorporating them
GB1529598A (en) Preparation of 3-cephem compounds
GB1324750A (en) Diacetate pharmaceutical preparations and manufacturing processes
GB1252373A (en)
GB1466857A (en) Urea tablets
GB1299037A (en) Dithiocarbamic acid esters
GB1287433A (en) Pharmaceutical compositions
GB1396840A (en) Sulphanilamides and a process for the manufacture thereof
GB1509778A (en) Pharmaceutical composition and dosage units thereof
GB1266430A (en)
GB1464878A (en) Salts of 2,6-dioxocyclohexane thiocarboxylic acid 4-halo- anilides and pharmaceutical compositions thereof
GB994350A (en) Improvements in or relating to pteridine compounds and processes for their preparation
GB1444527A (en) Guanidine derivatives
GB1261472A (en) Quinazolinone derivative